Rui Zhe Zhao

PacRim Venture Partners (PVP) is a venture capital firm founded in 1999 by Thomas J. Toy and Huoy-Ming Yeh. The firm is headquartered in Menlo Park, California.

Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California.

Part of Blackstone, Inc., Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd. is a Chinese company that provides investment management services. The company is based in Shime Yi, China.

Hangzhou New Horizon Health Technology Co., Ltd. is a private company that develops, manufactures, and wholesales medical diagnostics equipment for cancer screening. The company is based in Hangzhou, China.

Esco Lifesciences Group Ltd. is a multinational life sciences company, engages in the development, manufacture, and sale of life sciences, pharmaceutical and bioprocessing tools as well as the offering of related after-sales and support services. It operates through the following segments: Esco Scientific, Esco Medical, Esco Healthcare, and Esco Services. The Esco Scientific segment provides mission critical life sciences laboratory equipment such as biological safety cabinets, laminar flow clean benches, CO2 and CO2/O2 incubators, fume hoods, centrifuges and others used in research, clinical and industrial settings for preparation, cultivation, handling and analytical purposes. The Esco Medical segment manufactures and sells medical devices such as incubators, workstations, and consumables for IVF treatment. The Esco Healthcare segment provides pharmaceutical equipment and bioprocessing tools, primarily containment and isolation systems for the production of medicines, vaccines, and cell and gene therapies. The Esco Services segment offers after-sales and support services to customers of Esco Scientific, Esco Medical, and Esco Healthcare. The company was founded on February 1, 2021 and is headquartered in Singapore.

VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China.

VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction.

The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023.

MFVC, Inc. (Mobius Venture Capital) is a venture capital firm founded in 1996 by Brad A. Feld and Gary Edward Rieschel. The firm is headquartered in Boulder, Colorado.

Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China.

Sangon Biotech Engineering (Shanghai) Co. Ltd. is a holding company that engages in the life sciences research and development services. It provides chemical and biological reagents, deoxyribonucleic acid (DNA) synthesis, molecular biology kit, protein, antibody, and laboratory consumables. The company was founded by QiSong Wang in 2001 and is headquartered in Shanghai, China.

Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China.

Fujian Herui Gene Technology Co. Ltd. provides biotechnological services. It mainly engages in the medical research & experimental development, biotechnology equipment leasing and medical testing services. The company was founded on August 17, 2017 and is headquartered in Fuzhou, China.

Pacific Advantage (International) Ltd. provides marketing services. The private company is based in Hong Kong, Hong Kong. The Chinese company was founded in 2002 by Francis Wen-Hou Chen, Wayne Merrick, Hali Tsang.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

dMedClinical Co. Ltd., formerly known as Caidya, is a leading clinical research organization that offers medical writing services for clinical trials. The company is based in Shanghai, CN, and has subsidiaries in Germany, Switzerland, United States, United Kingdom, and China. The Chinese company uses a combination of industry-recognized, proprietary, and third-party technologies to ensure transparency and cost efficiency in clinical trials. The company specializes in infectious disease clinical trial services and provide expertise for therapeutic developments. dMedClinical Co. was founded in 2021 by Ling Shi Tan, who has been the CEO since then.